Language:
Search:
LOGIN
 

 

Summary Financial Results 

 For the year ended December 31, 2010

 Net sales (000)    

$1,104,700

 Income from continuing operations, 
 attributable to common shareholders (000) 

 $65,300

 Diluted Income per share (continuing  operations)

 $1.89

 Gross margin

 28.8%

 Dividends paid per share

 $.65

 Share price range

 $44.84 - $32.74

SITEMAP | Partnerships | Legal Notice | Visit WestPFSSolutions.com Copyright 2011 West Pharmaceutical Services, Inc.